Other Species / Isoforms
  SMAP-5 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S17
DFYQTSYSIDDQSQQ
0 1
SMAP-5 (human) DFYQTSYSIDDQSQQ S17
SMAP-5 iso3 (human) DFYQTSYSIDDQSQQ S17
SMAP-5 (mouse) GFYQTSYsIDEQSQQ S17-p
S25
IDDQSQQSyDyGGSG
0 1
SMAP-5 (human) IDDQSQQSyDyGGSG S25
SMAP-5 iso3 (human) IDDQSQQSYDYGGSG S25
SMAP-5 (mouse) IDEQSQQsyDyGGSG S25-p
Y26-p
DDQSQQSyDyGGSGG
0 2
SMAP-5 (human) DDQSQQSyDyGGSGG Y26-p
SMAP-5 iso3 (human) DDQSQQSYDYGGSGG Y26
SMAP-5 (mouse) DEQSQQsyDyGGSGG Y26-p
Y28-p
QSQQSyDyGGSGGPy
0 2
SMAP-5 (human) QSQQSyDyGGSGGPy Y28-p
SMAP-5 iso3 (human) QSQQSYDYGGSGGPY Y28
SMAP-5 (mouse) QSQQsyDyGGSGGPY Y28-p
Y35-p
yGGSGGPySkQyAGy
0 3
SMAP-5 (human) yGGSGGPySkQyAGy Y35-p
SMAP-5 iso3 (human) YGGSGGPYSKQYAGY Y35
SMAP-5 (mouse) yGGSGGPYSKQyAGC Y35
K37-ub
GSGGPySkQyAGyDy
0 1
SMAP-5 (human) GSGGPySkQyAGyDy K37-ub
SMAP-5 iso3 (human) GSGGPYSKQYAGYDY K37
SMAP-5 (mouse) GSGGPYSKQyAGCDy K37
Y39-p
GGPySkQyAGyDysQ
0 33
SMAP-5 (human) GGPySkQyAGyDysQ Y39-p
SMAP-5 iso3 (human) GGPYSKQYAGYDYSQ Y39
SMAP-5 (mouse) GGPYSKQyAGCDySQ Y39-p
Y42-p
ySkQyAGyDysQQGR
Upstream
0 304
Treatment
  • imatinib
SMAP-5 (human) ySkQyAGyDysQQGR Y42-p
SMAP-5 iso3 (human) YSKQYAGYDYSQQGR Y42
SMAP-5 (mouse) YSKQyAGCDySQQGR C42
Y44-p
kQyAGyDysQQGRFV
0 136
SMAP-5 (human) kQyAGyDysQQGRFV Y44-p
SMAP-5 iso3 (human) KQYAGYDYSQQGRFV Y44
SMAP-5 (mouse) KQyAGCDySQQGRFV Y44-p
S45-p
QyAGyDysQQGRFVP
Upstream
0 10
Treatment
  • ischemia
SMAP-5 (human) QyAGyDysQQGRFVP S45-p
SMAP-5 iso3 (human) QYAGYDYSQQGRFVP S45
SMAP-5 (mouse) QyAGCDySQQGRFVP S45
Y67-p
QPYTGQIyQPTQAYT
0 1
SMAP-5 (human) QPYTGQIyQPTQAYT Y67-p
SMAP-5 iso3 (human) QPYTGQIYQPTQAYT Y67
SMAP-5 (mouse) QTYTGQIYQPTQAYP Y67